SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-076789
Filing Date
2014-12-18
Accepted
2014-12-18 18:38:33
Documents
2
Period of Report
2014-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2344
2 EX-24 DOCUMENT attachment1.htm EX-24 5040
  Complete submission text file 0001209191-14-076789.txt   8731
Mailing Address 3005 FIRST AVENUE SEATTLE WA 98121
Business Address
Frohlich Mark W (Reporting) CIK: 0001420482 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36781 | Film No.: 141297306

Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2066960703
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)